Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
1/28/2022
NHC Holds the 2022 National Health Working Conference
1/28/2022
NMPA Suspends Import, Sales and Use of JWLS's Fat Emulsion Product in ...
1/27/2022
CDE Publicizes the List of Reference Formulations for GQCE Studies (55...
1/27/2022
CDE Issues the Technical Guidance on Clinical Protocol for Liraglutide...
1/27/2022
CDE Issues the Guidelines for Clinical Trial Protocol Design for Once ...
1/26/2022
NMPA Announces Package Insert Revision of Numerous Drug Products
1/26/2022
93 Listed MedPharm Cos Release 2021 Performance Guidance amid Weakness
1/26/2022
China Designates Shenzhen as Pilot Zone for Improved Market Access wit...
1/26/2022
Information Collection on the 7th VBP Initiated at Numerous Provinces
1/26/2022
BfV Warns German Pharma and Tech Firms About Being Targeted by Hacker...
1/26/2022
New Drug Approvals in 2021: 64 New Molecular Entities, 24 from Local P...
1/25/2022
Protecting Pharmaceutical Trademarks in China and Taiwan
1/25/2022
Five Chinese Drug Companies to Make Merck's Covid-19 Pills for Poor Co...
1/25/2022
BPL Wins Chinese Approval to Market ALBUMINEX 25% in China
1/25/2022
CDE Issues the Technical Guidance on Clinical Protocol for Teriparatid...
1/24/2022
Eluminex Biosciences Acquires Zuretinol Acetate from Retinagenix Holdi...
1/24/2022
Amagma Therapeutics Announces Strategic Partnership with Innovent Biol...
1/24/2022
Brukinsa: Launch Sequence of First Chinese Cancer Drug to Roll Out Int...
1/23/2022
WuXi STA Opens Its First Parental Formulation Manufacturing Line
1/21/2022
CDE Issues the Guidelines for Centralized Monitoring and Statistics of...
1/21/2022
Drug R&D and Product Registration News Digest January 2022 (3)
1/21/2022
Recent Executive Moves
1/20/2022
CDE Issues the Technical Guidance for Clinical Protocol Design of Long...
1/20/2022
CDE Issues the Technical Guidance on Clinical Protocol for Injectable ...
1/20/2022
Drug R&D and Product Registration News Digest January 2022 (2)
1/20/2022
Everest Boosts Covid Bet With New Licensing Deal Despite Crowded Field...
1/20/2022
Patent Linkage System in China: Foreign Entities May Meet New Challeng...
1/19/2022
In Depth: How China's Health-Care Mutual Aid Industry Folded in Just T...
1/19/2022
Anti-tumor Drugs Became the Hottest Treatments in December (PharmaDJ's...
1/19/2022
Lupin and Foncoo Enter Partnership for High Quality Generics in Chin...
Page:
151
/
774
Total number of articles:
23207
:
[First]
[<<]
[149]
[150]
[151]
[152]
[153]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit